156 related articles for article (PubMed ID: 19117390)
1. Dynamics of "flap" structures in three HIV-1 protease/inhibitor complexes probed by total chemical synthesis and pulse-EPR spectroscopy.
Torbeev VY; Raghuraman H; Mandal K; Senapati S; Perozo E; Kent SB
J Am Chem Soc; 2009 Jan; 131(3):884-5. PubMed ID: 19117390
[TBL] [Abstract][Full Text] [Related]
2. Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy.
Blackburn ME; Veloro AM; Fanucci GE
Biochemistry; 2009 Sep; 48(37):8765-7. PubMed ID: 19691291
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
Lee VS; Nimmanpipug P; Aruksakunwong O; Promsri S; Sompornpisut P; Hannongbua S
J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
[TBL] [Abstract][Full Text] [Related]
4. X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: agreement of time-resolved spectroscopy and molecular dynamics simulations.
Ringhofer S; Kallen J; Dutzler R; Billich A; Visser AJ; Scholz D; Steinhauser O; Schreiber H; Auer M; Kungl AJ
J Mol Biol; 1999 Mar; 286(4):1147-59. PubMed ID: 10047488
[TBL] [Abstract][Full Text] [Related]
5. Interflap distances in HIV-1 protease determined by pulsed EPR measurements.
Galiano L; Bonora M; Fanucci GE
J Am Chem Soc; 2007 Sep; 129(36):11004-5. PubMed ID: 17705389
[No Abstract] [Full Text] [Related]
6. Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing.
Sadiq SK; De Fabritiis G
Proteins; 2010 Nov; 78(14):2873-85. PubMed ID: 20715057
[TBL] [Abstract][Full Text] [Related]
7. Solute effects on spin labels at an aqueous-exposed site in the flap region of HIV-1 protease.
Galiano L; Blackburn ME; Veloro AM; Bonora M; Fanucci GE
J Phys Chem B; 2009 Feb; 113(6):1673-80. PubMed ID: 19146430
[TBL] [Abstract][Full Text] [Related]
8. A priori molecular descriptors in QSAR: a case of HIV-1 protease inhibitors. II. Molecular graphics and modeling.
Kiralj R; Ferreira MM
J Mol Graph Model; 2003 Jun; 21(6):499-515. PubMed ID: 12676237
[TBL] [Abstract][Full Text] [Related]
9. Rapid screening for HIV-1 protease inhibitor leads through X-ray diffraction.
Pillai B; Kannan KK; Bhat SV; Hosur MV
Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):594-6. PubMed ID: 14993705
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on inhibitors of HIV protease: a target for drug design.
Jayaraman S; Shah K
In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
[TBL] [Abstract][Full Text] [Related]
11. Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations.
Aruksakunwong O; Wittayanarakul K; Sompornpisut P; Sanghiran V; Parasuk V; Hannongbua S
J Mol Graph Model; 2006 Nov; 25(3):324-32. PubMed ID: 16504560
[TBL] [Abstract][Full Text] [Related]
12. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
[TBL] [Abstract][Full Text] [Related]
13. Conformational flexibility in the flap domains of ligand-free HIV protease.
Heaslet H; Rosenfeld R; Giffin M; Lin YC; Tam K; Torbett BE; Elder JH; McRee DE; Stout CD
Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):866-75. PubMed ID: 17642513
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of ligand-induced flap closing in HIV-1 protease approach X-ray resolution: establishing the role of bound water in the flap closing mechanism.
Singh G; Senapati S
Biochemistry; 2008 Oct; 47(40):10657-64. PubMed ID: 18785756
[TBL] [Abstract][Full Text] [Related]
15. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, evaluation, and crystallographic-based structural studies of HIV-1 protease inhibitors with reduced response to the V82A mutation.
Clemente JC; Robbins A; Graña P; Paleo MR; Correa JF; Villaverde MC; Sardina FJ; Govindasamy L; Agbandje-McKenna M; McKenna R; Dunn BM; Sussman F
J Med Chem; 2008 Feb; 51(4):852-60. PubMed ID: 18215016
[TBL] [Abstract][Full Text] [Related]
17. Expedient solid-phase synthesis of both symmetric and asymmetric diol libraries targeting aspartic proteases.
Shi H; Liu K; Leong WW; Yao SQ
Bioorg Med Chem Lett; 2009 Jul; 19(14):3945-8. PubMed ID: 19328682
[TBL] [Abstract][Full Text] [Related]
18. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models.
Steindl TM; Schuster D; Laggner C; Chuang K; Hoffmann RD; Langer T
J Chem Inf Model; 2007; 47(2):563-71. PubMed ID: 17381173
[TBL] [Abstract][Full Text] [Related]
19. Crucial roles of the subnanosecond local dynamics of the flap tips in the global conformational changes of HIV-1 protease.
Li D; Ji B; Hwang K; Huang Y
J Phys Chem B; 2010 Mar; 114(8):3060-9. PubMed ID: 20143801
[TBL] [Abstract][Full Text] [Related]
20. Experimental and 'in silico' analysis of the effect of pH on HIV-1 protease inhibitor affinity: implications for the charge state of the protein ionogenic groups.
Domínguez JL; Gossas T; Carmen Villaverde M; Helena Danielson U; Sussman F
Bioorg Med Chem; 2012 Aug; 20(15):4838-47. PubMed ID: 22743085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
